Scott Tyler Aaronson MD
Adjunct Professor, Psychiatry, University of Maryland School of Medicine Chief Science Officer, Institute for Advanced Diagnostics and Therapeutics, Sheppard Pratt Health System
Join to view full profile
6501 N Charles StTowson, MD 21204
Phone+1 410-938-3125
Fax+1 410-938-3111
Dr. Aaronson is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Scott Aaronson is a psychiatrist in Towson, MD and is affiliated with Sheppard Pratt Health System. He received his medical degree from Harvard Medical School and has been in practice 36 years. His research covers novel treatments for difficult to treat mood and anxiety disorders and includes multiple studies with psychedelics as well as experimental neuromodulation techniques. He has more than 100 publications and over 3000 citings.
Education & Training
Mass General Brigham/Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1981 - 1985
Harvard Medical SchoolClass of 1981
Certifications & Licensure
MD State Medical License 2001 - 2028
MA State Medical License 1982 - 2001
American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
Publications & Presentations
PubMed
- 2 citationsThe role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis.Guy M Goodwin, Scott T Aaronson, Oscar Alvarez, Robin Carhart-Harris, Megan Croal
Journal of Affective Disorders. 2026-08-01 - Combined Treatments in Psychiatry: Toward a True Synthesis.Andrew D van der Vaart, Scott T Aaronson
Focus. 2026-07-01 - 1 citationsEfficacy and Safety of a Single Dose of Psilocybin for Chronic Suicidal Ideation: An Open-Label Trial.Andrew van der Vaart, Jeffrey LaPratt, Kimberly Swartz, Audrey Shoultz, Margo Lauterbach
The Journal of Clinical Psychiatry. 2026-05-13
Press Mentions
New Clinical Trial Conducted at Sheppard Pratt Identifies Predictors of Response to Vagus Nerve Stimulation for Treatment-Resistant DepressionOctober 13th, 2025- Why You Should Care Who Controls PsychedelicsMay 7th, 2021
- Correction: COMPASS Pathways Establishes Centre of Excellence with Sheppard Pratt to Accelerate Research and Improve Patient Experience in Mental Health CareJanuary 8th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
